Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1985-8-1
|
pubmed:abstractText |
A single supervised oral dose of amoxycillin 3 g combined with clavulanic acid 125 mg as a suspension (Augmentin 3.125G) plus probenecid 1 g, cured 97 of 100 assessable patients who had uncomplicated anogenital gonorrhoea. Thirteen of the 100 patients were infected with penicillinase producing strains of Neisseria gonorrhoeae (PPNG) and 11 (85%) of these patients were cured, including one infected with a PPNG strain that was also resistant to spectinomycin. Another group of 93 assessable patients was treated with ampicillin 3 g plus probenecid 1 g, and only 85 (91%) patients were cured. Of the eight treatment failures in this group, five were found to be infected with PPNG strains. In a second study 144 assessable patients were treated with amoxycillin 3 g combined with clavulanic acid 250 mg, (Augmentin 3.250G) plus probenecid 1 g, and a 97% cure rate was again obtained. Five of seven (71%) patients infected with PPNG strains were cured. Although both Augmentin regimens were effective for treating gonorrhoea caused by PPNG and non-PPNG strains, side effects were noted in more patients treated with 250 mg clavulanic acid (24%) than with 125 mg clavulanic acid (5%). In addition, a similar cure rate was obtained in the three primary sites of infection, the urethra, cervix, and rectum.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/4007860-111119,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4007860-6118488,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4007860-6211217,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4007860-6365235,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4007860-6428699,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4007860-879738
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amoxicillin,
http://linkedlifedata.com/resource/pubmed/chemical/Clavulanic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Clavulanic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Probenecid
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0266-4348
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
168-71
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:4007860-Administration, Oral,
pubmed-meshheading:4007860-Amoxicillin,
pubmed-meshheading:4007860-Clavulanic Acid,
pubmed-meshheading:4007860-Clavulanic Acids,
pubmed-meshheading:4007860-Drug Combinations,
pubmed-meshheading:4007860-Female,
pubmed-meshheading:4007860-Gonorrhea,
pubmed-meshheading:4007860-Humans,
pubmed-meshheading:4007860-Male,
pubmed-meshheading:4007860-Probenecid
|
pubmed:year |
1985
|
pubmed:articleTitle |
Single dose oral amoxycillin 3 g with either 125 mg or 250 mg clavulanic acid to treat uncomplicated anogenital gonorrhoea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|